Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 237 participants.
Also called NCT04161001
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 237 participants
- Registry
-
NCT04161001
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT04161001. Randomized; double masking; primary purpose treatment. Start 2019-11-20 (anticipated); primary completion 2021-11-20 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451
- Condition
- Hypertension, Dyslipidemia
- Intervention (Drug)
- Amlodipine/Olmesartan 10/40mg (Combination drug), Ezetimibe/Rosuvastatin 10/20mg(Combination drug)
- Intervention (Drug)
- Olmesartan 40mg, Ezetimibe/Rosuvastatin 10/20mg(Combination drug)
- Intervention (Drug)
- Amlodipine/Olmesartan 10/40mg (Combination drug)
- Lead sponsor
- Daewoong Pharmaceutical Co. LTD.
Record details
- Record id
cardio:ct-nct04161001- Content hash
7c18904114c66065f84902b400780c4bcbf705ffabed9419cd8c53997c5680a7